Medical Weight Loss Treatment for Virginia Residents
Medically Supervised Weight Loss, Delivered Online
OmniRx Health providers are licensed by the Virginia Board of Medicine for comprehensive telehealth services statewide.
Whether you're in Virginia Beach, Richmond, or anywhere across Virginia — our board-certified providers are ready to see you.
Medical Weight Loss Treatment in Virginia
Our board-certified providers prescribe FDA-approved and physician-developed weight loss medications including GLP-1 agonists, customized to your health profile and goals.
No office visits required — 100% online consultations
FDA-approved and physician-developed medications
Personalized dosing protocols adjusted to your response
Ongoing provider support and check-ins throughout treatment
Medications shipped directly to your door from licensed pharmacies
Virginia spans from the DC suburbs to the Blue Ridge Mountains, the naval bases of Hampton Roads to the coalfields of Southwest Virginia. OmniRx Health serves this diverse Commonwealth—federal workers in Arlington, military families in Norfolk, tech professionals in the Dulles corridor, and families in the Shenandoah Valley. Our telehealth platform fits Virginia's varied lifestyles, from the fast pace of Northern Virginia to the relaxed charm of the Eastern Shore.
Available Treatments in Virginia
Our board-certified providers in Virginia can prescribe and manage the following treatment options
Semaglutide
Semaglutide is a GLP-1 receptor agonist that reduces appetite and slows gastric emptying, helping patients achieve significant, sustained weight loss. Originally developed for type 2 diabetes management, semaglutide has become one of the most clinically effective weight loss medications available.
Tirzepatide
Tirzepatide is a dual GLP-1 and GIP receptor agonist that produces even greater weight loss than semaglutide alone. It addresses appetite, blood sugar regulation, and metabolic rate through two complementary hormonal pathways for superior outcomes.
Tesofensine
Tesofensine is a triple monoamine reuptake inhibitor that suppresses appetite and boosts metabolism through dopamine, norepinephrine, and serotonin pathways. Originally developed as an anti-Parkinson's agent, it showed exceptional weight loss properties in clinical trials.
Retatrutide
Retatrutide (LY3437943) is a 39-amino acid synthetic peptide and triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Currently in Phase 3 clinical trials (TRIUMPH program), it produced 24.2% average weight loss at 48 weeks in Phase 2 data — the highest weight reduction observed in any peptide trial to date. Listed by OmniRx for research-use only (RUO).
Telehealth Regulations in Virginia
State Licensing
OmniRx Health providers are licensed by the Virginia Board of Medicine for comprehensive telehealth services statewide.
Telehealth Law
Virginia has progressive telehealth laws that support comprehensive virtual care delivery throughout the Commonwealth.
Pharmacy Access
Virginia's extensive pharmacy network in NOVA, Richmond, Hampton Roads, and throughout the state ensures prescription access.
Insurance Notes
Virginia requires telehealth coverage parity, and Medicaid has expanded virtual care benefits for eligible residents.
Frequently Asked Questions
Common questions about medical weight loss and telehealth access in Virginia
Explore Related Medical Weight Loss Pages
Direct links to specific treatments and other states.